Core Viewpoint - A class action lawsuit has been filed against Civitas Resources, Inc. for allegedly misleading investors about its production capabilities and financial condition during the specified class period [1][2]. Allegations - Civitas is accused of failing to disclose significant reductions in oil production expected in 2025 due to declines after a production peak in Q4 2024 and a low TIL count at the end of 2024 [2]. - The company would need to acquire additional acreage and development locations to increase oil production, which would incur significant debt and potentially require selling corporate assets [2]. - Financial conditions would necessitate disruptive cost-reduction measures, including a significant workforce reduction [2]. - The company's business and financial prospects, as well as operational capabilities, were allegedly overstated [2]. Stock Price Impact - Following the revelation of these issues on February 24, 2025, Civitas's stock price dropped by $8.95 per share, representing a decline of over 18%, closing at $40.35 per share on February 25, 2025 [2]. Class Action Participation - Shareholders may be eligible to participate in the class action, with a deadline to file as lead plaintiff by July 1, 2025 [3]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [3]. Company Background - Civitas Resources, Inc. is an independent exploration and production company focused on crude oil and liquids-rich natural gas in the Denver-Julesburg Basin in Colorado and the Permian Basin in Texas and New Mexico [1].

Group 1 - A class action has been filed on behalf of investors who purchased PepGen Inc. (NASDAQ:PEPG) securities between March 7, 2024, and March 3, 2025 [1] - PepGen is a clinical-stage biotechnology company focused on developing oligonucleotide therapeutics for severe neuromuscular and neurologic diseases, with its lead product candidate being PGN-EDO51 for Duchenne muscular dystrophy (DMD) [1] - Allegations against PepGen include misleading investors about the effectiveness and safety of PGN-EDO51, deficiencies in the CONNECT2 study, and overstated clinical and commercial prospects [2] Group 2 - On January 29, 2025, PepGen reported safety concerns in the CONNECT1 study and FDA concerns regarding the CONNECT2 study, leading to a stock price drop of $0.40 per share (21.74%) [3] - Following a press release on March 4, 2025, announcing a voluntary pause of the CONNECT2 study, PepGen's stock price fell by $0.53 per share (18.86%) [4] - Shareholders interested in participating in the class action must file a motion for lead plaintiff by August 8, 2025 [5]

Core Viewpoint - Besra Gold Inc. has issued a statement addressing misleading claims made by Quantum Metal Recovery Inc., emphasizing that Quantum's actions could harm shareholder value and that Besra's independent directors are exploring legal options to counter these misrepresentations [1][2]. Group 1: Misrepresentations and Legal Actions - Quantum has allegedly made material misrepresentations regarding Besra's operations and the status of the Bau Gold Project, which is not yet a producing mine [3][4]. - The lawsuit initiated by Quantum claims that Besra's board has acted oppressively towards Quantum's interests, despite Quantum's nominees having significant representation on the board [4][6]. - Besra's independent directors are concerned about Quantum's attempts to remove them, which they believe could lead to irreversible damage to shareholder value [1][2]. Group 2: Financial Obligations and Project Delays - Quantum has failed to remit funds under the gold purchase agreement (GPA), with a payment of approximately US$9.83 million due in December 2023 not received, leading to legal action from other shareholders [9]. - The renewal of Besra's mining tenements has been delayed, impacting the development of the Bau Gold Project, although renewals were initiated in 2024 [9][10]. Group 3: Governance and Shareholder Meeting - The upcoming special meeting of shareholders is scheduled for June 24, 2025, where critical decisions regarding board composition and governance will be made [2][22]. - Besra's independent directors are urging shareholders to vote against Quantum's nominees and to support the removal of Dato' Lim Khong Soon from the board [21][27]. Group 4: Quantum's Compliance Issues - Quantum has been accused of disregarding corporate and securities laws, including failing to comply with insider reporting obligations despite owning approximately 29.88% of Besra's voting securities [14][16]. - The Securities Commission of Malaysia has previously directed Quantum to cease offering its securities to the public due to legal violations [14].

SAN DIEGO, June 11, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP announces that a class action lawsuit has commenced on behalf of investors of Fortrea Holdings Inc. (NASDAQ: FTRE). The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) Fo ...

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Archer-Daniels-Midland Company (NYSE: ADM) on behalf of long-term stockholders following a class action complaint that was filed against ADM on January 24, 2024 with a Class Period from April 30, 2020 through January 22, 2024. Our investigation concerns whether the board of directors of ADM have breached their fiduciary duties to the company. ...

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GrafTech International Ltd. (NYSE: EAF) on behalf of long-term stockholders following a class action complaint that was filed against GrafTech on January 25, 2024 with a Class Period from  February 8, 2019 through August 3, 2023. Our investigation concerns whether the board of directors of GrafTech have breached their fiduciary duties to the ...

Core Viewpoint - A class action lawsuit has been filed against Vestis Corporation for allegedly misleading investors about customer growth and strategic initiatives [1][2]. Allegations - The complaint claims that Vestis Corporation did not disclose its inability to execute planned strategic initiatives aimed at improving customer experience and onboarding, which were expected to drive new customer growth and retention [2]. - It is alleged that these misleading statements led to investors purchasing Vestis securities at artificially inflated prices [2]. Financial Results and Market Reaction - On May 7, 2025, Vestis announced disappointing financial results for Q2 of fiscal 2025, withdrew its revenue guidance for the full year, and provided third-quarter guidance that was significantly below market expectations [3]. - The company attributed its poor performance to "lost business in excess of new business" and "lower adds over stops," indicating a decline in volume changes with existing customers [3]. - Following this announcement, Vestis' stock price plummeted from $8.71 per share on May 6, 2025, to $5.44 per share on May 7, 2025, marking a decline of approximately 37.54% in just one day [3]. Class Action Participation - Shareholders interested in participating in the class action must file a motion for lead plaintiff by August 8, 2025, with the lead plaintiff representing other class members in the litigation [4]. - Shareholders can choose to remain absent from the case while still being eligible for recovery [4]. Company Background - Robbins LLP, the firm leading the class action, specializes in shareholder rights litigation and has been active in helping shareholders recover losses and improve corporate governance since 2002 [5].

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against SoundHound AI, Inc. (NASDAQ:SOUN) on behalf of long-term stockholders following a class action complaint that was filed against SoundHound on March 28, 2025 with a Class Period from May 10, 2024 and March 3, 2025. Our investigation concerns whether the board of directors of SoundHound have breached their fiduciary duties to the company. Accor ...

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Red Cat Holdings, Inc. (NASDAQ: RCAT) and Fortrea Holdings Inc. (NASDAQ:FTRE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Red Cat Holdings, Inc. (NASDAQ: RCAT) Class Period: M ...

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who acquired Reckitt Benckiser Group PLC American Depository Shares (ADSs) between January 13, 2021, and July 28, 2024, alleging that the company misled investors regarding the safety of its Enfamil baby formula [1][2]. Allegations - The lawsuit claims that Reckitt failed to inform investors and consumers about the increased risk of necrotizing enterocolitis (NEC) in preterm infants consuming its cow's milk-based formula, Enfamil, and the potential negative impact on sales and legal exposure [2]. - A jury in Illinois awarded $60 million in a case against Mead Johnson, finding negligence in failing to warn about the risks associated with cow's milk-based formula, which led to a significant drop in Reckitt's ADS price [3]. - Following a similar case in Missouri, where Abbott Laboratories was found liable for NEC-related damages, Reckitt's ADS price also experienced a notable decline [4]. Class Action Participation - Shareholders interested in serving as lead plaintiffs in the class action must file a motion by August 4, 2025, but participation is not required to be eligible for recovery [5].